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INTRODUCTION 
Several investigators have demonstrated in experimental and clinical 
situations, that leukocyte activation with release of sometimes toxic 
mediators occurs in trauma and sepsis. This has been proposed as one 
important etiologic factor in the development of the systemic inflammatory 
response Syndrome, which often leads to multiorgan dysfunct ion. 
Granulocytes (PMNs) are the fastest acting cells of the inflammatory 
response mechanism and thus constitute the focus of endothelial cell-
leukocyte interactions. Activat ion of PMNs occurs via humoral products 
(e.g., C5a), bacterial products, e.g., endotoxin (LPS), chemotactic Peptides 
or cytokines, e.g., tumor necrosis factor and interleukin-8. The involved 
mediators produce up-regulation/loss of adherence molecules, increase 
adhesion and the respiratory burst, and trigger the release of oxygen 
radicals and enzymes. 
Leukocyte Activators 
( T r a u m a ^ 
activated 
Complement 
translocated 
L P S and 
formed Cytokines 
( S e p s i s ^ 
Endotoxin and Bacteria 
TNF, IL-1, IL-8 
i activated Complement 
Leuko Leuko 
F i g . 1: 
P o s s i b l e s o u r c e s o f m e d i a t o r s , w h i c h c a n l e a d t o l e u k o c y t e a c t i v a t i o n . 
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C a u s e s of Leukocyte Act iva t ion-Trauma (Fig. 1) 
Three events are most important for mediator release leading to 
leukocyte activation during hemorrhagic shock and Polytrauma: 
- Ischemia- or soft t issue trauma-related complement activation 
- Bacterial translocation due to underperfusion of the splanchnic area 
(see also Schlag, et al . , 1991). 
- Ischemia caused by hemorrhage-induced hypovolemia 
Complement 
After trauma probably the most prominent activators of leukocytes are 
activated complement products e.g. anaphylatoxins (C3a, C5a) and 
terminal complement complex (TCC). In a recently performed Polytrauma 
study (56 patients, ISS score 33 - 7 5 , mean 46 with 14 % mortality) only 
complement activation (C3a/C3 ratios) and granulocyte activation were 
significantly different between non-survivors and survivors on day 1 after 
trauma (Roumen, et al . , 1993) and T C C as well as elastase correlated 
significantly with the degree of injury (ISS-score). Further significant 
correlations were found between A P A C H E II, and C 3 a / C 3 . 
Cytokines 
Most recently, bioactive TNF release has been reported to occur after 
hemorrhage (Ayala, et al . , 1990). The same group also reported the 
significance of this finding for immunosuppression, since the use of anti-
TNF (antibody) treatment reduced mortality from subsequent sepsis (Ertel, 
et al . , 1990). These studies provide a possible link between the reported 
immunosuppression and the overactivation of other immune responses, 
e.g., PMN activation by cytokines. There is now first evidence that the 
TNF found after hemorrhagic shock and trauma at least partially is due to 
endotoxin induction (Tab. 1) and more convincing evidence in most recent 
studies without and with anti-LPS therapeutic agents (Bahrami, et al. 
submitted). A lso in baboon hemorrhagic shock, endotoxin and bacterial 
translocation were found (Schlag, et. al. , 1991). 
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Table 1. P l a s m a e n d o t o x i n l e v e l s ( p g / m l j i n p l a s m a o f r a t s s u b j e c t e d t o 
h e m o r r h a g i c s h o c k ( 9 0 m i n u t e s ) ( f r o m S c h l a g , e t a l . , 1 9 9 3 ) . 
Groups Time (min) 
0 90 120 
SHAM 7.7 ± 9.3 6.7 ± 13.5 9.2 ± 12.1 
(n = 5) 
CONTROL SHOCK 17.6 ± 34.0 23.4 ± 32.0 9.8 ± 15.3 
(n = 5) 
Measurable plasma TNF levels were found frequently at the end or 90 
minutes fol lowing shock (Tab. 2) in this model, which could be blocked by 
administration of anti-TNF antibody T N 3 . Such therapeutic Intervention 
(pretreatment) was found to be beneficial for 48 hour mortality in this 
model (Tab. 3) (Schlag, et al . , 1993). 
Table 2 . TNF l e v e l s f p g / m l ) i n p l a s m a o f r a t s s u b j e c t e d t o h e m o r r h a g i c 
s h o c k w i t h a n d w i t h o u t TNF a n t i b o d y ( T N 3 ) a p p l i c a t i o n ( f r o m S c h l a g , e t a l . 
1 9 9 3 ) . 
Groups Time (min) 
0 90 120 
SHAM (n - 5) 
CONTROL SHOCK (n = 4) 
TN3 (n = 5) 
< 20 
< 20 
< 20 
< 20 
78 ± 50 
< 20 
< 20 
57 ± 98 
< 20 
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Table 3 . 4 8 h o u r s m o r t a l i t y i n r a t h e m o r r h a g i c s h o c k w i t h a n d w i t h o u t TNF 
a n t i b o d y ( T N 3 ) a p p l i c a t i o n ( S c h l a g , e t a l . 1 9 9 3 ) . 
Groups 24 hours 4 8 hours 
CONTROL SHOCK (n = 10) 50 % 7 0 % 
TN3 (n = 10) 3 0 % 4 0 % 
In a further hemorrhagic shock study in rats, TNF levels were elevated 
5 hours after shock and resuscitation, but not at 1 hour. A good 
correlation was found between adherent leukocytes measured with 
intravital liver microscopy and TNF plasma levels (r = 0 .56, p < 0.01). 
Administrat ion of anti-TNFab reduced the TNF plasma levels. There was 
not only an influence on adherence, but generally on perfusion, as base 
excess values were significantly improved in the treated shock group from 
- 5.6 ± 0.8 mEq/L (shock only) to 4.1 ± 0.7 mEq/L (shock + anti-TNFab). 
(Marzi, et al . , 1993) 
Evidence of Leukocyte Act ivat ion-Trauma 
Considerable differences between animal models and human septic 
shock have been revealed with respect to proteolytic enzymes and their 
endogenous inhibitors. Thus, the most relevant data on the role of 
proteinases, especially concerning P M N elastase, in human sepsis have 
been obtained from primate or clinical studies reviewed below, since e.g. 
sheep (Junger, et al . , 1992) or pig (Geiger, et al. , 1988) have neutrophils 
different from humans. 
With regard to the pathological mechanisms involved in severe 
inflammation, the neutral Protease, elastase, from the azurophilic granules 
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of the P M N granulocytes, Stands out as being significant among the 
lysosomal phagocyte enzymes currently recognized. Elastase is not only 
numerically predominant (3 - 5 J J Q H O PMN cells) but also has practically 
no Substrate specificity in the neutral pH ränge. The latter was shown by 
the nonspecif ic degradation of a great variety of humoral and structural 
proteins such as clotting, fibrinolysis, complement factors, 
Immunoglobulins, transport proteins, and Proteinase inhibitors as well as 
basal membrane proteins, cell receptors, fibronectin, elastin, collagen, 
proteoglycans, etc. (for review Jochum; 1993a, 1993b). 
F i g . 2 : 
D i f f e r e n c e s i n e l a s t a s e p l a s m a l e v e l s w i t h r e g a r d t o m o r t a l i t y ( m e a n ± 
S E M ) . P M N e l a s t a s e p l a s m a l e v e l s , s e l e c t e d a s a p a r a m e t e r o f P M N 
a c t i v a t i o n , w e r e s i g n i f i c a n t l y h i g h e r i n P o l y t r a u m a p a t i e n t s ( I S S > 3 0 ) w h o 
d i e d w i t h i n t h e f i r s t d a y s a f t e r t h e a c c i d e n t . ( D a t a f r o m a m u l t i c e n t e r 
P o l y t r a u m a s t u d y i n c o l l a b o r a t i o n w i t h A . A a s e n , H . B e n z e r , I. G o r i s , R. 
R o u m e n , a n d W. S a n d t n e r ) . ( D a t a f r o m R e d l , e t a l . , 1 9 9 3 a ) 
Such PMN activation is reliably demonstrated by measuring elastase 
release (i.e., plasma elastase levels). Various research groups have 
successful ly used this method in the clinical setting and could demonstrate 
that massive activation of PMNs with subsequent elastase release was 
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predictive of the subsequent development of multiorgan failure (MOF) 
(Lang, et al . , 1989; Nast-Kolb, et al. , 1992). Elastase levels were also 
significantly higher in Polytrauma patients who died within the first days 
after the accident (Fig. 2). Düring the ICU stay the greatest differences 
between patients with and without multi-organ failure (MOF) were found 
for PMN-elastase (Roumen, et al . , 1993). 
In 24 multiply injured patients, primary activation of P M N granulocytes 
immediately after the Polytrauma is fol lowed by repetitive increases of 
complexed elastase in plasma in those patients who developed A R D S and 
additional organ failure (Jochum, et al . , 1989). This multiple organ 
insufficiency was mainly due to septic complications. In agreement with 
findings of Nuytinck et al. (1 986),elevated plasma levels of elastase 
correlated well with the severity of injuries and the occurrence of multiple 
organ failure. Moreover, they discriminated to a reasonable degree at an 
early stage in the clinical course between later survival or mortality. 
In a large study with 100 multiply traumatized patients (ISS > 29), 
inflammatory mediators with special emphasis on granulocyte activation 
were studied (Nast-Kolb, et al. , 1992). Retrospectively, the patients were 
assigned to three different groups: 16 of them died due to multiple organ 
failure 3 - 28 days (mean survival time: 16 days) after the traumatic 
incident (group I), 47 patients survived the development of organ failure 
(group II) and 37 patients overcame the accident without evident signs of 
organ dysfunct ions (group III). P M N elastase was elevated in all groups 
significantly above normal (upper ränge 120 ng/ml) as early as 1 - 2 h after 
trauma and showed an additional increase up to the 1 2th h after trauma. 
The differences between mean plasma levels in patients with (groups I and 
II) and those without organ failure (group III) were highly significant (p < 
0.01) throughout the whole Observation period. Moreover, patients dying 
due to organ failure (group I) and those who survived organ dysfunct ions 
(group II) could be also significantly (p < 0.05) differentiated according to 
their mean P M N elastase plasma concentrations from the 3rd posttraumatic 
day onwards. Elastase indeed appears to be not only a marker of severity 
of injury and a mediator leading to proteolysis of a great variety of normal 
tissue substances, but also a factor significantly correlating with final 
outcome. 
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C a u s e s of Leukocyte Act ivat ion-Sepsis (Fig. 1) 
Complement 
In vivo studies, together with several in vitro studies, indicate that E. 
coli bacteria and endotoxin may initiate the complement cascade. 
Incubation of fresh human serum with different amounts of E. coli bacteria 
or LPS led to the formation of the terminal C5b-9 complement complex and 
to the formation of C3a (Fig. 3). Polysaccharide components from the cell 
walls of gram-negative bacteria activate the cascade nonspecifically while 
lipid A is able to initiate the classical pathway. However, Keil and 
coworkers (1990) have demonstrated that l ipopolysaccharide (Salmonella 
minnesota endotoxin) induces activation of the complement cascade solely 
via the alternative pathway. 
ng C3a/ml 
1600 
1200 
800 
400 
0 0,1 
ug LPS/ml 
F i g . S.-
F o r m a t i o n o f C 3 a b y l i p o p o l y s a c c h a r i d e ( 0 . 1 p g / m l ) i n c u b a t e d f o r 15 m i n 
a t 3 7 °C w i t h f r e s h h u m a n p l a s m a ( M e a n v a l u e s a n d S E M ) f r o m 
B e n g t s s o n , e t a l . , 1 9 9 3 . 
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Bengtsson, et al . , (1993) performed a study to determine whether 
infusion of different amounts of live E. coli activates the complement 
cascade and whether there is a relationship between the activation of 
complement and the release of lysosomal enzymes from activated 
leukocytes as well as between plasma endotoxin levels and the degree of 
complement activation. 
o 
In that study infusion of the different amounts of E. coli (5 x 10 , 2.5 x 
1 0 1 ^ live bacteria per kilogram body weight) led to increased P M N elastase 
levels in circulating blood. This was in contrast to the effects on 
o 
complement of the lowest dose of infused E. coli bacteria (5 x 10 ) which 
did not significantly change the plasma levels of the terminal C5b-9 
complement complex, or at least such changes were not detectable with 
our assay System. The correlation between the plasma levels of the 
terminal C5b-9 complement complex and P M N elastase was positive. 
However, this does not answer the question of whether activation of 
complement leads to leukocyte activation with the release of P M N elastase 
or whether leukocyte activation leads to complement activation or if 
leukocyte activation instead is due to cytokine release. TNF alpha, IL-1, 
and IL-8 are especially potential candidates, since P M N have been shown 
to have receptors for these three cytokines. 
In the study of Bengtsson, et al. (1993) there was only a very weak 
correlation between the plasma concentrations of terminal C5b-9 
complement complex and the levels of endotoxin (LPS). However, in a 
recent study, Brandtzaeg and coworkers (1989) showed that in patients 
with systemic meningococcal disease there was a strong correlation 
between the formation of terminal C5b-9 complement complex and plasma 
levels of endotoxin (lipopolysaccharide) on admission (r = 0 .76, n = 39 , 
P < 0.001). Van Deventer, et al. (1990) have studied activation of 
complement and neutrophils in relation to the appearance of tumor 
necrosis factor (TNF) in the circulation. In experimental endotoxemia in 
humans they demonstrated marked neutropenia shortly after increase of 
circulating TNF, and at a period with no signs of activation of the 
complement cascade. 
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Cytokines 
In sepsis there is both a direct action of LPS as well as a cytokine effect 
on leukocytes. LPS is one of the major inducers of cytokine release. It has 
been reported that bolus endotoxin administration (4 ng/kg) in humans 
results in a rapid rise (up to 300 ± 150 pg/l) and a subsequently fall in 
circulating TNF levels (Fromm, et al . , 1988 ; Zabel, et al., 1990). In 
experimental studies, detectable plasma TNF levels are found between 1 h 
and 3 h after endotoxemia in mice, rats (Bahrami, et al., 1991), sheep 
(Traber, et al . , 1 993), and baboons (Lindsey, et al., 1 991). 
Chemotactic NAP-1/ IL-8 might be considered a potentially important 
mediator of leukocyte activation in endotoxin shock. Based on the fact that 
endotoxin and TNF can induce IL-8 production from monocytes and 
endothelial cells (Strieter, et al . , 1989), one might anticipate the presence 
of elevated levels of IL-8 with septic shock, especially following the 
attainment of the serum TNF peak. We have demonstrated the in vivo 
appearance of IL-8 in baboons during lethal E. coli bacteremia with peak 
levels 4 hours after sepsis induction (Redl, et al., 1991a). Patients with 
septic shock had significantly higher levels of IL-8 than other categories of 
meningococcal patients, and high levels of IL-8 were associated with fatal 
septic shock (Haistensen, et al . , 1993). IL-8 in vivo was also demonstrated 
in sublethal endotoxemia and after administration of human recombinant IL-
1 (van Zee, et al . , 1991). The appearance of IL-8 in septicemia was found 
to fol low the kinetics of IL-1 and IL-6 appearance, which peaked much 
later than TNF (Redl, et al. , 1991a). IL-8 kinetics in baboons were found to 
be different from those reported in human volunteers, in whom the plasma 
peak was found 2 h after LPS infusion (Martich, et al., 1991). This 
difference is probably due to the time required for LPS release from 
bacteria in vivo in the baboon study versus the infusion of free LPS in the 
human study. 
Evidence of Leukocyte Act ivat ion-Sepsis 
Elastase levels in the baboon were much higher in severe sepsis than in 
trauma (Tab. 4). 
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T a b l e 4. P l a s m a l e v e l s o f P M N s p e c i f i c e l a s t a s e i n b a b o o n e x p e r i m e n t s 
w i t h P o l y t r a u m a ( w i t h l o w c i r c u l a t i n g e n d o t o x i n , p e a k l e s s t h a n 2 0 0 p g 
L P S / m l p l a s m a ) o r b a c t e r e m i a ( w i t h h i g h c i r c u l a t i n g e n d o t o x i n a t 2 h o u r s i n 
t h e ränge o f 1 1 , 0 0 0 p g L P S / m l p l a s m a ) . I n s e p s i s e l a s t a s e l e v e l s a r e 
s t a t i s t i c a l l y d i f f e r e n t f r o m e l a s t a s e l e v e l s i n h y p o v o l e m i c t r a u m a t i c s h o c k 
(p < 0 . 0 5 ) u s i n g W i l c o x o n s t a t i s t i c s ( R e d l , e t a l . , 1 9 9 1 b ) . 
Hypovolemic/ 
Groups traumatic 
(hrs/animal) Sepsis shock 
0 6 ± 1.3 15 ± 2 
2 270 ± 45.0* 30 ± 6 
4 262 ± 26.0* 62 ± 8 
6 388 ± 31.0* 77 ± 15 
8 304 ± 27.0 ND 
T a b l e 5. P M N e l a s t a s e r e l e a s e a n d i t s p l a s m a l e v e l s a r e d e p e n d e n t o n E. c o l i 
d o s e i n b a b o o n b a c t e r e m i a ( f r o m B e n g t s s o n , e t a l . , 1 9 9 3 ) . 
PMN elastase 0 
(ng/ml) 
5x10 8 E.col i 7 ± 1 
2.5 x 1 0 9 E . coli 3 ± 2 
1 0 1 0 E. coli 6 ± 1 
2h 4h 
21 ± 5 36 ± 14 
118 ± 1 0 33 ± 13 
156 ± 9 159 ± 6 
6h 8h 
59 ± 25 62 ± 28 
149 ± 14 139 ± 19 
166 ± 10 161 ± 7 
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One reason for the higher activation State of leukocytes in the model 
could be the E.coli related release of endotoxin into the plasma (maximum 
11 ng/ml), which was below 0.2 ng/ml in our trauma animals. In sepsis, 
granulocyte activation (PMN release) was found to be dependent on the 
dose of administered E. coli (Tab. 5) (Bengtsson, et al., 1993). 
Al though in recent studies, gram-negative bacteria have not been 
recognized as the etiologic agent in more than half of the patients 
presenting Symptoms of sepsis-like Syndrome (Glauser, et al . , 1991), the 
effects of bacterial endotoxin, a l ipopolysaccharide (LPS) from the cell wall 
of gram-negative bacteria, has been characterized in detail in numerous 
studies. Endotoxin administration to human volunteers activated most of 
the relevant humoral and cellular cascade Systems and produced 
cardiovascular changes that were qualitatively similar to those seen in 
septic shock (Parrillo, et al . , 1990). 
In several prospective clinical studies of more than 200 patients 
suffering from bacterial infections after major surgery or trauma, an 
increased release of P M N elastase into the circulation in accordance with 
worsening of the inflammatory reaction was demonstrated (Duswald, et 
al . , 1985 ; Pacher, et al . , 1989, Nuytinck, et al. 1986, Jochum, et al . , 
1990). Patients without postoperative infections showed only moderate 
transiently elevated plasma levels of complexed elastase (up to three times 
that of normal) after Operation, whereas onset and course of sepsis were 
characterized by markedly increased concentrations up to 30-fold in 
individual patients. In patients with persisting septicemia, the elastase 
plasma levels remained significantly elevated until death, while a recovery 
phase was accompanied by an obvious return to normal values. 
In a study by Inthorn et al. (1987), P M N activation was demonstrated in 
postoperative and septic patients by whole-blood chemiluminescence as a 
measure of oxygen radical formation during phagocytosis. Significant 
correlation was also found between elastase activity in bronchoalveolar 
lavage fluid (BALF) samples and the respiratory index of the septic shock 
patients, thus suggesting that at least local tissue damage in sepsis and 
M O F may be in part due to the destructive potency of PMN elastase 
(Tanaka, et al . , 1991). 
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Among many other inflammation markers, only P M N elastase showed 
an obvious correlation with infection or sepsis (Waydhas, et al . , 1992). 
Since significantly higher plasma levels of elastase were measurable even 
before onset of infection or sepsis compared to a similar posttraumatic 
course without such complicat ions, the conclusion can be drawn that 
granulocytic Proteinase may facilitate and maintain the occurrence of 
posttraumatic infections and sepsis by interfering with the immune System. 
In addition to measurements of the complexed elastase in plasma of 
adults, serial quantifications of this granulocytic Proteinase in 306 
neonates, carried out by Speer and Tegtmeyer (1989), have proven that 
this inflammatory mediator is both a highly sensitive and rapidly responsive 
indicator of neonatal septicemia and a helpful tool in monitoring the course 
of the disease. When patients with neonatal septicemia were differentiated 
from those with other neonatal disorders, elevated complexed elastase 
levels showed a sensitivity of 95 % and specificity of 81 % for the septic 
entity. Similar results were published by Tsaka and Herkner (1990) on 135 
newborn infants. Not only elastase antigen was found in many studies but 
the activity could also be demonstrated indirectly. In patients with lethal 
outcome, the generation of the elastase-induced fibrinogen split product 
"fibrino-elastase peptide (FEP)" (Gippner-Steppert, 1991) in the circulation 
was well correlated with high plasma levels of P M N elastase. 
Interactions Endothe l ium/Leukocvtes 
Adhesion Molecules 
A distinct series of events fol lows activation of EC by LPS or cytokines. 
The properties of the endothelium inducible in vitro by LPS and cytokines 
include cytokine expression, procoagulant activity, immunologic 
funct ions, and increased adnesiveness for leukocytes due to expression 
of adherence molecules. There are several families involved both at the 
endothelial and leukocyte level (Tab. 6). 
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Table 6. A d h e s i o n m o l e c u l e s o n e n d o t h e l i a l a n d l e u k o c y t e s u r f a c e s . 
Endothelium - P-selectin (GMP-140) 
- E-selectin (ELAM-1) 
- ICAM-1 
- VCAM-1 
Leukocyte - CD18 Complex 
- L-selectin (LAM-1) 
- VLA4 
Molecules involved on the endothelium are GMP-140/P-select in (Geng, 
et al . , 1990) and platelet activating factor (PAF) (Zimmermann et al., 
1990). G M P - 1 4 0 is located in the Weibel-Palade bodies, is transported to 
the cell surface upon Stimulation and binds leukocytes via a lectin-like 
domain. 
E-select in/ELAM-1 serves to bind PMNs via fucosylated 
polylactosamines with the critical determinant sialyl-Lewis-X (Phillips, et 
al. , 1990). ELAM-1 is not present on unstimulated EC in vitro and may 
transiently be induced (peak at 4 - 6 h) by LPS, IL-1 alpha, IL-1ß, TNF, or 
lymphotoxin (Leeuwenberg, et al . , 1989). In addition to two selectins on 
the endothelial cells, another selectin (L-selectin) was found on 
lymphocytes, monocytes, and neutrophils and previously called L A M - 1 , 
Leu-8 (Mel-14 in mouse cells) (McEver, 1991). 
The CDw1 8 complex is part of the supergene integrin family and 
consists of glycoproteins arranged in one ß- chain (CD18) and three 
different alpha-chains ( C D 1 1 a o r CD11b or CD11 c). Their expression 
can be influenced by several inflammatory mediators. Studies suggest 
that CD11 b/CD1 8 are not only involved in adherence, but also directly 
trigger toxicity of TNF-act ivated P M N (van Asmuth et al. 1991). 
Intracellular storage pools of CD11 b and CD18 exist in circulating 
granulocytes (secondary and tertiary granules). Upon activation, the P M N 
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produce a marked increase of the surface expression of C D 1 1 b / C D 1 8 
within minutes. Chemoattractants activate (upregulate) the avidity of 
integrins on neutrophils by conformational changes, as indicated by 
the reactivity of particular mAbs (Tonnesen, et al . , 1989). Most recent 
data indicate that the avidity of CD11b may be reversibly altered without 
changes in the number of cell surface receptors by a newly recognized lipid 
molecule, which was termed integrin modulating factor (IMF-1) 
(Hermanowski-Vosatka, et al . , 1992). In vivo evidence of increased 
CD11 b/CD1 8 expression was found e.g. in burn patients (Nelson, et al . , 
1986). 
One important aspect of rolling (and especially retarded rolling due to 
the combined action of G M P - 1 4 0 and ICAM-1) is the prolonged contact 
between the endothelium and P M N , which allows more efficient exposure 
of P M N to chemoattractants such as PAF or IL- 8, which as a function of 
vascular tone in low-f low areas finally leads to st icking, spreading and 
transmigration via the ICAM-1/CD1 8 mechanism (Smith, et al . , 1988). 
Systemic (de novo) expression of adhesion molecules occurs under 
septic condit ions in subprimate animal models (Redl, et al. , 1991b) 
demonstrated by using two different antibodies to the ELAM-1 structure in 
kidney, liver, lung, heart and skin biopsies. With the use of skin biopsies it 
was possible to establish the kinetic expression pattern, which was most 
prominent at 4 - 6 hr and not detectable after 1 0 - 2 4 hr. This is in general 
agreement with septic shock studies on Cynomolgous monkeys 
(Engelberts, et al . , 1992) where LPS infusion induced a generalized E L A M -
expression most pronounced in the vasculature of lung tissue and skin. 
Again serial skin biopsies showed the onset of E L A M expression at 2 hr 
and maximum at 4 hr. Both studies showed that in contrast to earlier 
f indings, E L A M expression was not restricted to postcapillary venules. 
Circulating endotoxin levels in plasma are several log-steps higher in sepsis 
than in trauma, which might explain the lower endothelial activation in 
trauma (Fig. 4). Nevertheless, small amounts of endotoxin and cytokines 
seen after Polytrauma due to bacterial translocation (Schlag, et al . , 1991) 
could account for the few positive endothelial stainings in the trauma 
animals (Fig. 4). 
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Degree of 
ELAM expression (0-3) 
Septic Shock Traumatlc Shock 
SS 
Lung Llver Kidney Skin 
F i g . 4: 
I n c i d e n c e o f i m m u n o h i s t o c h e m i c a l i d e n t i f i c a t i o n o f t h e a d h e r e n c e 
m o l e c u l e E L A M - 1 i n b a b o o n t i s s u e f r o m d i f f e r e n t o r g a n s a f t e r P o l y t r a u m a 
( L P S < 2 0 0 p g / m l p l a s m a ) o r s e p s i s ( L P S « 1 1 , 0 0 0 p g / m l p l a s m a ) ( d a t a 
f r o m R e d l , e t a l . , 1 9 9 1 c ) . 
140 
120 
100 
80 
60 
40 
20 
ng Elastase/ml 
H Control 
BS TNF-AB 15 mg/kg 
10 24 
hours 
F i g . 5: 
G r a n u l o c y t e e l a s t a s e l e v e l s i n s e p t i c b a b o o n s (E. c o l i i n f u s i o n b e t w e e n BL a n d 
2 h o u r s ) . A n t i - T N F a b t r e a t m e n t ( 1 5 mgCBß/kg BW) (n = 4 ) s i g n i f i c a n t l y 
r e d u c e d I L - 8 a n d e l a s t a s e l e v e l s ( c o n t r o l s n = 7) ( f r o m R e d l , e t a l . , 1 9 9 3 a ) . 
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In order to establish the role of LPS vs. cytokines for endothelial 
activation in vivo (baboon model), we ended a sepsis experiment at 8 hrs 
in several animals and noted significant ELAM-1 expression. In two animals 
pretreatment with anti-TNF antibody (TNF-AB) was performed. Tissues 
sampled showed diminished expression of ELAM-1 in several organs, 
despite high circulating levels of LPS. 
Most recent data show that IL-8 (a major P M N activator) expression in 
baboon septicemia can be suppressed efficiently by eliminating TNF, using 
a T N F - A B at 15 mg/kg (Redl, et al . , 1993a). The same model showed a 
decrease in elastase levels under TNF-blocked condit ions, emphasizing 
nicely the TNF-inf luence on PMN-act ivat ion (Fig. 5). 
In agreement with previous in vitro TNF Stimulation experiments (van 
Asmuth , et al . , 1991), almost no s E L A M can be found after 4 hr of 
incubation in the presence of high levels of surface E L A M , while after 24 
hr of incubation with LPS , surface E L A M decreased to detection limit 
levels while s E L A M increased (Redl, et al. , 1993c) . A comparable pattern 
of in vivo sELAM-re lease was found in septic baboons (Fig. 6). 
ng soluble ELAM/ml 
hours 
F i g . 6: 
S o l u b l e E L A M p l a s m a l e v e l s i n s e p t i c b a b o o n s (n = 5 ) i n f u s e d w i t h 10r 
C F U / k g l i v e E. c o l i o v e r a p e r i o d o f 2 h o u r s ( s E L A M - E L I S A b y B r i t i s h 
B i o t e c h n o l o g y ) . ( f r o m R e d l , e t a l . , 1 9 9 3 c ) 
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The importance of P M N for tissue damage in general and in particular 
The role of adhesion (molecule) upregulation during PMN activation has 
been confirmed in numerous studies with experimentally induced 
leukopenia, where organ damage, e.g. in the lung, could be prevented (e.g. 
Heflin, et al . , 1981). 
The importance of adhesion is emphasized by therapeutic use of 
monoclonal antibodies (60.3, IB4) against the common CD-18 ß-chain. 
These antibodies possess a protective potential in hypovolemic shock 
(Vedder, et al . , 1988) and against LPS-induced leukostasis (Cooper, et al . , 
1989) and sepsis induced lung injury (Walsh, et al. , 1991). 
Similar to anti-CD1 8, anti-CD11 a and anti-CD11 b M o A b s were found to 
be tissue-protective. Blockade of ICAM-1 on the endothelium provides a 
protective effect in isolated lungs (Barton, et al. , 1989) and in the 
mesenteric circulation of rabbits with zymosan-plasma infusion 
(Argenbright, et al . , 1991a). Both pretreatment with anti-ICAM-1 and anti-
CD11 /1 8 was effective, while only anti-CD1 1 a and anti-CD1 8 were able to 
displace already adherent leukocytes. Furthermore, antibodies against 
CD18/ ICAM-1 effectively inhibited the development of the local 
Shwartzman response in rabbit skin (Argenbright, et al., 1991b). However, 
there is recent evidence that in septic baboons ant i -CD18 antibody 
treatment causes severe organ damage and does not improve survival rates 
(Redl, et al . , 1993b). 
Conc lus ion 
From the current literature and from in vivo studies in primates we 
conclude that leukostasis occurs both after trauma and sepsis, but is 
more marked in sepsis. There is clear evidence of PMN activation both in 
trauma and sepsis, but again sepsis constitutes a much stronger trigger. 
Endothelial cells are probably involved in leukostasis, especially during 
sepsis when EC are "act ivated" by de novo expression of adhesion 
molecules such as E L A M - 1 . This is hardly seen after trauma, when only 
low levels of LPS or cytokines are found. In addition to neutralization of de 
novo expressed (or upregulated) adhesion molecules by monoclonal 
antibodies, the reduction of P M N and EC activation should be considered 
as the primary therapeutic goal in the posttraumatic Situation. Therapeutic 
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approaches should include elimination of mediators (LPS, TNF) with e.g. 
rBPI or anti-TNF antibody therapy. 
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